openPR Logo
Press release

Thyroid Cancer Drugs Market To Make Huge Impact In Near Future Basic Influencing Factors Driving The Industry 2018–2026 Estimated By Global Players Biovista, Vascular Biogenics, Azaya Therapeutics, Bionomics, Bayer

03-07-2019 12:40 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Global Thyroid Cancer Drugs Market

Global Thyroid Cancer Drugs Market

In the recent past, increasing number of thyroid cancers were diagnosed at an early stage of the treatment as several new technologies has arrived with drugs. Advanced treatments resulting into long term survival, minimum complications of surgery and improved quality of life in a cost-effective way. The main types of thyroid cancer includes differentiated, medullary, and anaplastic thyroid cancer. Among these, anaplastic thyroid cancer is characterized with an aggressive undifferentiated tumor. Apart from these, the other types of thyroid cancer includes thyroid lymphomas, thyroid sarcomas, parathyroid cancer or other rare thyroid tumors.

Get Exclusive Sample Report at: https://www.coherentmarketinsights.com/insight/request-sample/1710

Thyroid Cancer Drugs Market Drivers:

Increasing prevalence of thyroid cancer is expected to drive growth of the thyroid cancer drugs market. For instance, according to National Cancer Institute (NCI), 2013-2015 data findings, around1.2% of men and women are expected to be diagnosed with thyroid cancer at some point during their lifetime, in the U.S. Moreover, according to the NCI 2018 data findings, in 2018, there were an estimated 53,990 new cases of thyroid cancer and an estimated 2,060 people are expected to die due to thyroid cancer, in the U.S. Moreover, according to Cancer Research UK, 2015 data findings, in the U.K. there were 3,528 new cases of thyroid cancer registered in 2015. According to the same source, thyroid cancer accounted to register 1% of all cancer cases in 2015, which includes 27% of thyroid cancer cases in males, and 73% in females, in the U.K. Furthermore, according to Cancer Research UK, the lifetime risk of developing thyroid cancer is around 1 in 480 for men and around 1 in 180 for women, in 2012 in the U.K.

In 2016, according to the American Cancer Society, anaplastic thyroid cancer accounts for 2% of all thyroid cancers, in North America. FDA granted several programs, in order to increase availability of drugs to treat serious diseases. In May 2018, Food and Drug Administration (FDA) approved a combination of two targeted drugs, dabrafenib plus trametinib, to treat patients with anaplastic thyroid cancer. The combination of Tafinlar (dabrafenib) and Mekinist (trametinib) is the first FDA approved treatment for these type of thyroid cancers. Moreover, in 2015, FDA approved Lenvatinib for the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer. In November 2013, U.S. FDA approved Nexavar (sorafenib) to treat patients with Stage IV thyroid cancer. Moreover, the drug is already present in the market for the treatment of liver and kidney cancer.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/thyroid-cancer-drugs-market-1710

Furthermore, thyroid cancer drug rejection, owing to incompetence of drug in providing efficient output to thyroid cancer patients, is expected to be a major restraining factor for growth of market. For instance, in October 2017, National Institute for Health and Care Excellence (NICE), rejected Bayer’s Nexavar and Eisai’s Lenvima in thyroid cancer, stating that neither of this drugs are cost-effective against thyroid cancer treatment.

Thyroid Cancer Drugs Market - Regional Analysis:

Geographically, thyroid cancer drugs market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America holds the dominant position in thyroid cancer drugs market. This is owing to growing prevalence of thyroid cancer in this region. According to National Cancer Institute (NCI) 2018 data findings, in 2015, there were an estimated 765,547 people living with thyroid cancer in the U.S. Moreover, according to the same source, an estimated 53,990 new cases of thyroid cancer are expected to be registered in 2018, representing 3.1% of all new cancer cases, in 2018.

Global Key Players:

Some of the key players operating in thyroid cancer drugs market include
Biovista,Vascular Biogenics,Azaya Therapeutics,Bionomics,Bayer,Eisai,Bio-Path Holdings,Takeda Pharmaceutical Company,GlaxoSmithKline plc,AstraZeneca plc.

Thyroid Cancer Drugs Market Taxonomy:

By Drug Type:
Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Cometriq (Cabozantinib-S-Malate), Lenvatinib Mesylate, Nivolumab, Vandetanib, Others

By End Users:
Hospitals, Oncology Clinics, Research Organizations, Others

By Geography:
North America, Latin America, Europe, Asia Pacific, Middle East, Africa

Get Instant Discount | Contact us at: https://www.coherentmarketinsights.com/insight/request-discount/1710

Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at sales@coherentmarketinsights.com

https://www.coherentmarketinsights.com/phase-xs/

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Thyroid Cancer Drugs Market To Make Huge Impact In Near Future Basic Influencing Factors Driving The Industry 2018–2026 Estimated By Global Players Biovista, Vascular Biogenics, Azaya Therapeutics, Bionomics, Bayer here

News-ID: 1639383 • Views:

More Releases from Coherent Market Insights

Global Antihistamine Drugs Market Expected to Expand at a Steady 2024-2031 | Bayer AG, Almirall  S.A, GlaxoSmithKline, Johnson and Johnson.
Global Antihistamine Drugs Market Expected to Expand at a Steady 2024-2031 | Bay …
Coherent Market Insights introduces new research on the Global Antihistamine Drugs Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The report also
Incretin Mimetics Market Future Business Opportunities 2024-2031 | GSK, Novo Nordisk, Lily, Haosoh, Sanofi, AstraZeneca, Pfizer Inc.
Incretin Mimetics Market Future Business Opportunities 2024-2031 | GSK, Novo Nor …
Coherent Market Insights introduces new research on the Incretin Mimetics Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The report also focuses
Skin Rash Treatment Market Huge Growth in Future Scope 2024-2031 | AbbVie, Amgen, Bristol Myers Squibb, Galderma, Johnson & Johnson.
Skin Rash Treatment Market Huge Growth in Future Scope 2024-2031 | AbbVie, Amgen …
Coherent Market Insights introduces new research on the Skin Rash Treatment Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The report also
Global Vitamin API Market Growth in Future Scope 2024-2031 | DSM, BASF, BOC Sciences, CSPC Pharmaceutical Group Limited.
Global Vitamin API Market Growth in Future Scope 2024-2031 | DSM, BASF, BOC Scie …
Coherent Market Insights introduces new research on the Global Vitamin API Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The report also

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top